Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1946 1
1947 4
1948 1
1949 1
1950 3
1952 1
1954 2
1958 1
1959 2
1960 1
1963 2
1965 2
1967 1
1968 1
1969 1
1970 2
1972 1
1973 4
1974 5
1975 9
1976 8
1977 9
1978 4
1979 5
1980 9
1981 6
1982 4
1983 11
1984 7
1985 7
1986 9
1987 8
1988 4
1989 8
1990 12
1991 12
1992 14
1993 13
1994 19
1995 19
1996 23
1997 15
1998 20
1999 16
2000 28
2001 37
2002 33
2003 28
2004 36
2005 42
2006 40
2007 43
2008 42
2009 38
2010 46
2011 68
2012 35
2013 45
2014 33
2015 37
2016 37
2017 50
2018 44
2019 45
2020 54
2021 56
2022 55
2023 11
Text availability
Article attribute
Article type
Publication date

Search Results

1,203 results
Results by year
Filters applied: . Clear all
Page 1
Lecanemab in Early Alzheimer's Disease.
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. van Dyck CH, et al. Among authors: kramer ld. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL. Swanson CJ, et al. Among authors: kramer ld. Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8. Alzheimers Res Ther. 2021. PMID: 33865446 Free PMC article. Clinical Trial.
Emerging Tick-Borne Diseases.
Madison-Antenucci S, Kramer LD, Gebhardt LL, Kauffman E. Madison-Antenucci S, et al. Among authors: kramer ld. Clin Microbiol Rev. 2020 Jan 2;33(2):e00083-18. doi: 10.1128/CMR.00083-18. Print 2020 Mar 18. Clin Microbiol Rev. 2020. PMID: 31896541 Free PMC article. Review.
The β-Secretase BACE1 in Alzheimer's Disease.
Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, Nisticò R, Corbo M, Imbimbo BP, Streffer J, Voytyuk I, Timmers M, Tahami Monfared AA, Irizarry M, Albala B, Koyama A, Watanabe N, Kimura T, Yarenis L, Lista S, Kramer L, Vergallo A. Hampel H, et al. Among authors: kramer l. Biol Psychiatry. 2021 Apr 15;89(8):745-756. doi: 10.1016/j.biopsych.2020.02.001. Epub 2020 Feb 13. Biol Psychiatry. 2021. PMID: 32223911 Free PMC article. Review.
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A. Petersen E, et al. Among authors: kramer ld. Int J Infect Dis. 2022 Jan;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 1. Int J Infect Dis. 2022. PMID: 34863925 Free PMC article. No abstract available.
International Journal of Infectious Diseases: from the past quarter-century to the next.
Petersen E, Lee SS, Blumberg L, Kramer LD, Obiero C, Al-Abri S, Abubakar A, Pinto TCA, Yapi BR, Tambyah PA, Holmes AH. Petersen E, et al. Among authors: kramer ld. Int J Infect Dis. 2021 Aug;109:36-37. doi: 10.1016/j.ijid.2021.06.064. Epub 2021 Jul 1. Int J Infect Dis. 2021. PMID: 34217873 Free PMC article. No abstract available.
Cocaine Triggers Astrocyte-Mediated Synaptogenesis.
Wang J, Li KL, Shukla A, Beroun A, Ishikawa M, Huang X, Wang Y, Wang YQ, Yang Y, Bastola ND, Huang HH, Kramer LE, Chao T, Huang YH, Sesack SR, Nestler EJ, Schlüter OM, Dong Y. Wang J, et al. Among authors: kramer le. Biol Psychiatry. 2021 Feb 15;89(4):386-397. doi: 10.1016/j.biopsych.2020.08.012. Epub 2020 Aug 25. Biol Psychiatry. 2021. PMID: 33069367 Free PMC article.
Editorial overview.
Kramer LD, Long MT. Kramer LD, et al. Curr Opin Virol. 2017 Dec;27:iv-v. doi: 10.1016/j.coviro.2017.11.011. Curr Opin Virol. 2017. PMID: 29223217 No abstract available.
The Origin of COVID-19 and Why It Matters.
Morens DM, Breman JG, Calisher CH, Doherty PC, Hahn BH, Keusch GT, Kramer LD, LeDuc JW, Monath TP, Taubenberger JK. Morens DM, et al. Among authors: kramer ld. Am J Trop Med Hyg. 2020 Sep;103(3):955-959. doi: 10.4269/ajtmh.20-0849. Am J Trop Med Hyg. 2020. PMID: 32700664 Free PMC article.
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL. Swanson CJ, et al. Among authors: kramer ld. Alzheimers Res Ther. 2022 May 21;14(1):70. doi: 10.1186/s13195-022-00995-9. Alzheimers Res Ther. 2022. PMID: 35598024 Free PMC article. No abstract available.
1,203 results